Your browser doesn't support javascript.
loading
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
Shawe-Taylor, Marianne; Greenwood, David; Hobbs, Agnieszka; Dowgier, Giulia; Penn, Rebecca; Sanderson, Theo; Stevenson-Leggett, Phoebe; Bazire, James; Harvey, Ruth; Libri, Vincenzo; Kassiotis, George; Gamblin, Steve; Lewis, Nicola S; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Carr, Edward J; Wu, Mary Y; Bauer, David L V; Wall, Emma C.
Afiliação
  • Shawe-Taylor M; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Greenwood D; The Francis Crick Institute, London NW1 1AT, UK.
  • Hobbs A; COVID Surveillance Unit, London NW1 1AT, UK.
  • Dowgier G; COVID Surveillance Unit, London NW1 1AT, UK.
  • Penn R; The Francis Crick Institute, London NW1 1AT, UK.
  • Sanderson T; The Francis Crick Institute, London NW1 1AT, UK.
  • Stevenson-Leggett P; COVID Surveillance Unit, London NW1 1AT, UK.
  • Bazire J; COVID Surveillance Unit, London NW1 1AT, UK.
  • Harvey R; Worldwide Influenza Centre, London NW1 1AT, UK.
  • Libri V; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK.
  • Kassiotis G; The Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
  • Gamblin S; The Francis Crick Institute, London NW1 1AT, UK.
  • Lewis NS; Worldwide Influenza Centre, London NW1 1AT, UK.
  • Williams B; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
  • Swanton C; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Gandhi S; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Carr EJ; The Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.
  • Wu MY; The Francis Crick Institute, London NW1 1AT, UK.
  • Bauer DLV; The Francis Crick Institute, London NW1 1AT, UK; Genotype-to-Phenotype 2 Consortium (G2P2-UK), UK.
  • Wall EC; The Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre and NIHR UCLH Clinical Research Facility, London, UK. Electronic address: emma.wall@crick.ac.uk.
Lancet ; 403(10432): 1133-1136, 2024 Mar 23.
Article em En | MEDLINE | ID: mdl-38484752
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido